bibliographic entry 8105516 [be/8105516]
https://w3id.org/oc/corpus/be/8105516

is a
content
  • Lioznov M, El-Cheikh J Jr, Hoffmann F, Hildebrandt Y, Ayuk F, Wolschke C et al. Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells. Bone Marrow Transplant 2010; 45: 349–353. PMID: 19584825
references